AI Agents in Healthcare and Life Sciences: Use Cases and Implementation
AI agents in healthcare and life sciences should own a bounded operating goal, not an unlimited business function. This application note shows a credible use case, the evidence the agent needs and the decisions that remain with people.
What an AI agent means in healthcare and life sciences
An AI agent is software that can pursue a goal across several steps. It observes the current situation, chooses from available actions, uses approved tools and checks whether the action moved the work towards the goal. The ability to choose a next step distinguishes an agent from a chatbot that only returns an answer.
In healthcare and life sciences, autonomy must be defined against the operating reality. A complex referral can depend on symptoms, prior investigations, appointment capacity, clinical priority and eligibility. Delay often comes from missing evidence and unclear ownership rather than the clinical consultation itself. A useful agent therefore works inside a named process, with known evidence, permitted actions and a clear point at which a person takes control.
A strong use case: care-pathway co-ordination for complex referrals
A practical agent could assemble permitted records, check referral completeness, identify the correct pathway, find an available appointment, explain missing evidence and present the case to a clinician when judgement is required. The agent adds value because the right next action depends on evidence that changes from case to case. A rigid sequence would either stop at every exception or push a poor decision through the same route as a routine one.
This is a prospective application, not a claim about a completed Marketways engagement. The design should begin with observed work and real exception histories. The agent should first run in a shadow mode that prepares a recommendation while the existing team continues to decide.
The agent needs an operating contract
The operating contract states the goal, inputs, tools, permitted actions, prohibited actions and escalation conditions. The agent must not diagnose, change clinical priority or communicate a material clinical decision without authorised professional review. Every action should produce a trace that shows the evidence used, the rule or model consulted, the tool called and the result.
The relevant evidence includes clinical records, referral criteria, capacity, policy rules, review outcomes, safety incidents and patient experience. Systems Mapping and Architecture identifies the systems and decision rights around the agent. Human-in-the-Loop and Control Design defines when the system proceeds, pauses or hands control to a person.
Test business performance, not conversational polish
The main measures are complete referrals, waiting time, avoidable rework, safe escalation and patient access across groups. The test set must include ordinary cases, rare exceptions, conflicting evidence and unavailable tools. A fluent explanation does not compensate for a wrong action, a missed escalation or an incomplete record.
Marketways separates model evaluation from workflow evaluation. The model must retrieve, classify or predict reliably. The complete operating loop must also move work, respect authority and improve the business outcome when compared with the current process.
How to implement the agent
Start with the Marketways industry context and one bounded decision. Map the current process through Process Mapping and Analysis, define the data and tool permissions, build the smallest useful action loop, and run it beside the current team. Expand authority only when observed performance and control evidence support the change.
Agentic AI Design and Deployment connects the technical architecture with roles, controls and operational ownership. The companion article on AI workflow automation in healthcare and life sciences explains the more deterministic alternative.